PDS Biotechnology Corpora...

NASDAQ: PDSB · Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.22
1.66%
After-hours: Aug 15, 2025, 07:12 PM EDT

PDS Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 59.07K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 15.13K 29.53K 15.13K 15.13K 14.4K 14.4K 14.4K 74.66K 74.37K 11.57K n/a 60.26K 60.34K 61.21K 61.53K n/a n/a
Gross Profit
n/a -15.13K 29.53K -15.13K -15.13K -14.4K -14.4K -14.4K -74.66K -74.37K -11.57K -97.67K -60.26K -60.34K -61.21K -61.53K -61.53K -62.12K
Operating Income
-7.62M -9.11M -7.36M -10.18M -8.68M -10.1M -10.41M -10.52M -12.7M -9.42M -18.82M -7.28M -7.09M -8.48M -6.32M -6.96M -5.11M -3.05M
Interest Income
333.62K 377.85K 503.94K 666.77K 675.21K 668.89K 683.54K 739.4K 750.65K 729.34K 854.93K 145.25 74.55K 5.7K 1.73K 1.36K 604.00 655.00
Pretax Income
-9.43M -9.66M -7.95M -10.73M -9.2M -10.6M -10.9M -10.85M -12.94M -9.66M -19.14M -7.42M -7.02M -8.47M -6.32M -6.96M -5.11M -3.05M
Net Income
-9.43M -8.49M -7.95M -10.73M -8.33M -10.6M -10.9M -10.85M -11.54M -9.66M -19.14M -7.42M -5.82M -8.47M -6.32M -6.96M -589K -3.05M
Selling & General & Admin
3.41M 3.27M 2.83M 3.38M 4.16M 3.38M 2.93M 4.07M 4.69M 3.58M 2.67M 2.93M 3.33M 3.32M 2.93M 3.27M 2.34M 1.64M
Research & Development
4.21M 5.83M 4.53M 6.8M 4.53M 6.7M 7.47M 6.45M 8.01M 5.84M 16.16M 4.35M 3.76M 5.16M 3.39M 3.69M 2.76M 1.41M
Other Expenses
n/a n/a -16K n/a -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
7.62M 9.11M 7.34M 10.18M 8.68M 10.08M 10.39M 10.52M 12.7M 9.42M 18.82M 7.28M 7.09M 8.48M 6.32M 6.96M 5.11M 3.05M
Interest Expense
2.14M 930.88K 1.1M 1.22M 1.19M 1.18M 1.18M 1.07M 995.4K 966.85K 1.25M 145.25K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -14.4K -14.4K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.62M 9.11M 7.36M 10.18M 8.68M 10.1M 10.41M 10.52M 12.7M 9.42M 18.82M 7.28M 7.09M 8.48M 6.32M 6.96M 5.11M 3.05M
Income Tax Expense
n/a -1.17M n/a n/a -869K 5.00 n/a -4.73K -1.41M -3.15K 1.2M n/a -1.2M -5.7K n/a -60.26K -4.52M n/a
Shares Outstanding (Basic)
45.9M 40.52M 36.45M 36.81M 36.69M 34.82M 31.67M 30.91M 30.8M 30.43M 28.77M 28.46M 28.45M 26.16M 28.43M 28.43M 23.16M 22.26M
Shares Outstanding (Diluted)
45.9M 40.52M 36.45M 36.81M 36.69M 34.82M 31.67M 30.91M 30.8M 30.43M 28.77M 28.46M 28.45M 26.16M 28.43M 28.43M 23.16M 22.26M
EPS (Basic)
-0.21 -0.21 -0.22 -0.29 -0.23 -0.3 -0.34 -0.35 -0.37 -0.32 -0.75 -0.26 -0.2 -0.32 -0.22 -0.24 -0.03 -0.14
EPS (Diluted)
-0.21 -0.21 -0.22 -0.29 -0.23 -0.3 -0.34 -0.35 -0.37 -0.32 -0.75 -0.26 -0.2 -0.32 -0.22 -0.24 -0.03 -0.14
EBITDA
-7.29M -8.72M -6.84M -9.5M -7.99M -9.41M -9.71M -9.77M -11.87M -8.62M -18.81M -7.18M -7.02M -8.41M -6.32M -6.96M -5.11M -3.05M
EBIT
-7.29M -8.73M -6.86M -9.51M -8.01M -9.43M -9.72M -9.78M -11.95M -8.69M -17.89M -7.03M -7.02M -8.47M -6.32M -6.96M -5.11M -3.05M
Depreciation & Amortization
n/a 5.46K 15.13K 15.13K 15.13K 14.4K 14.4K 14.4K 74.66K 74.37K 11.57K 97.67K 60.26K 60.34K 951.00 1.27K 1.27K 1.86K